RETRACTED: Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
Valentina Zuco(Fondazione IRCCS Istituto Nazionale dei Tumori), Franco Zunino(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 62
Related Papers
Cellular Effects and Antitumor Activity of RET Inhibitor RPI-1 on MEN2A-Associated Medullary Thyroid Carcinoma
|JNCI Journal of the National Cancer Institute|2004|112
Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid
|Cell Death and Differentiation|2003|54
Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds
|Molecular Cancer Therapeutics|2008|54